nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—CYP2B6—Thiotepa—sarcoma	0.161	0.18	CbGbCtD
Rilpivirine—ABCG2—Dactinomycin—sarcoma	0.11	0.123	CbGbCtD
Rilpivirine—ABCG2—Mitoxantrone—sarcoma	0.0981	0.11	CbGbCtD
Rilpivirine—ABCG2—Vincristine—sarcoma	0.0675	0.0757	CbGbCtD
Rilpivirine—ABCG2—Etoposide—sarcoma	0.0619	0.0694	CbGbCtD
Rilpivirine—CYP1A2—Dacarbazine—sarcoma	0.0522	0.0585	CbGbCtD
Rilpivirine—CYP3A4—Thiotepa—sarcoma	0.0493	0.0553	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—sarcoma	0.0422	0.0473	CbGbCtD
Rilpivirine—ABCB1—Dactinomycin—sarcoma	0.0395	0.0443	CbGbCtD
Rilpivirine—ABCB1—Mitoxantrone—sarcoma	0.0354	0.0397	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—sarcoma	0.0297	0.0333	CbGbCtD
Rilpivirine—CYP1A2—Etoposide—sarcoma	0.0255	0.0286	CbGbCtD
Rilpivirine—ABCB1—Vincristine—sarcoma	0.0244	0.0273	CbGbCtD
Rilpivirine—ABCB1—Etoposide—sarcoma	0.0223	0.025	CbGbCtD
Rilpivirine—CYP3A4—Mitoxantrone—sarcoma	0.0212	0.0238	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—sarcoma	0.0152	0.0171	CbGbCtD
Rilpivirine—CYP3A4—Vincristine—sarcoma	0.0146	0.0164	CbGbCtD
Rilpivirine—CYP3A4—Etoposide—sarcoma	0.0134	0.015	CbGbCtD
Rilpivirine—CYP3A4—Doxorubicin—sarcoma	0.00912	0.0102	CbGbCtD
Rilpivirine—Pazopanib—FLT1—sarcoma	0.00416	0.26	CrCbGaD
Rilpivirine—Pazopanib—PDGFRB—sarcoma	0.00344	0.215	CrCbGaD
Rilpivirine—Pazopanib—PDGFRA—sarcoma	0.00335	0.209	CrCbGaD
Rilpivirine—Bilirubin total increased—Epirubicin—sarcoma	0.00283	0.0307	CcSEcCtD
Rilpivirine—Bilirubin total increased—Doxorubicin—sarcoma	0.00262	0.0284	CcSEcCtD
Rilpivirine—Pazopanib—KDR—sarcoma	0.00261	0.163	CrCbGaD
Rilpivirine—Pazopanib—KIT—sarcoma	0.00246	0.154	CrCbGaD
Rilpivirine—White blood cell count decreased—Mitoxantrone—sarcoma	0.00245	0.0266	CcSEcCtD
Rilpivirine—Transaminases increased—Thiotepa—sarcoma	0.00232	0.0252	CcSEcCtD
Rilpivirine—Platelet count decreased—Mitoxantrone—sarcoma	0.00205	0.0222	CcSEcCtD
Rilpivirine—Serum creatinine increased—Mitoxantrone—sarcoma	0.00198	0.0215	CcSEcCtD
Rilpivirine—Hepatotoxicity—Dactinomycin—sarcoma	0.00182	0.0197	CcSEcCtD
Rilpivirine—Haemoglobin decreased—Mitoxantrone—sarcoma	0.00177	0.0192	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Thiotepa—sarcoma	0.00149	0.0162	CcSEcCtD
Rilpivirine—Opportunistic infection—Epirubicin—sarcoma	0.00141	0.0153	CcSEcCtD
Rilpivirine—Hepatotoxicity—Etoposide—sarcoma	0.00131	0.0142	CcSEcCtD
Rilpivirine—Opportunistic infection—Doxorubicin—sarcoma	0.00131	0.0142	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Mitoxantrone—sarcoma	0.00129	0.014	CcSEcCtD
Rilpivirine—Inflammation—Etoposide—sarcoma	0.00105	0.0113	CcSEcCtD
Rilpivirine—Blood creatinine increased—Thiotepa—sarcoma	0.00096	0.0104	CcSEcCtD
Rilpivirine—Transaminases increased—Epirubicin—sarcoma	0.000935	0.0101	CcSEcCtD
Rilpivirine—Serum creatinine increased—Epirubicin—sarcoma	0.000925	0.01	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.000923	0.01	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.000916	0.00993	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Thiotepa—sarcoma	0.000904	0.0098	CcSEcCtD
Rilpivirine—Transaminases increased—Doxorubicin—sarcoma	0.000865	0.00938	CcSEcCtD
Rilpivirine—Serum creatinine increased—Doxorubicin—sarcoma	0.000855	0.00927	CcSEcCtD
Rilpivirine—Blood creatinine increased—Mitoxantrone—sarcoma	0.000829	0.00899	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Vincristine—sarcoma	0.000819	0.00887	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.000797	0.00864	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.000781	0.00846	CcSEcCtD
Rilpivirine—Renal failure—Thiotepa—sarcoma	0.000777	0.00842	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Thiotepa—sarcoma	0.000747	0.0081	CcSEcCtD
Rilpivirine—Urinary tract disorder—Thiotepa—sarcoma	0.0007	0.00759	CcSEcCtD
Rilpivirine—Depression—Vincristine—sarcoma	0.000699	0.00757	CcSEcCtD
Rilpivirine—Urethral disorder—Thiotepa—sarcoma	0.000695	0.00754	CcSEcCtD
Rilpivirine—Renal failure—Mitoxantrone—sarcoma	0.000671	0.00727	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Etoposide—sarcoma	0.000649	0.00704	CcSEcCtD
Rilpivirine—Immune system disorder—Thiotepa—sarcoma	0.000641	0.00694	CcSEcCtD
Rilpivirine—Mental disorder—Thiotepa—sarcoma	0.000621	0.00674	CcSEcCtD
Rilpivirine—Urinary tract disorder—Vincristine—sarcoma	0.000621	0.00673	CcSEcCtD
Rilpivirine—Malnutrition—Thiotepa—sarcoma	0.000617	0.00669	CcSEcCtD
Rilpivirine—Urethral disorder—Vincristine—sarcoma	0.000616	0.00668	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Epirubicin—sarcoma	0.000601	0.00652	CcSEcCtD
Rilpivirine—Creatinine increased—Epirubicin—sarcoma	0.000597	0.00648	CcSEcCtD
Rilpivirine—Inflammation—Epirubicin—sarcoma	0.000586	0.00636	CcSEcCtD
Rilpivirine—Abnormal dreams—Epirubicin—sarcoma	0.000562	0.00609	CcSEcCtD
Rilpivirine—Renal failure—Etoposide—sarcoma	0.000558	0.00605	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Doxorubicin—sarcoma	0.000556	0.00603	CcSEcCtD
Rilpivirine—Creatinine increased—Doxorubicin—sarcoma	0.000553	0.00599	CcSEcCtD
Rilpivirine—Mental disorder—Vincristine—sarcoma	0.000551	0.00597	CcSEcCtD
Rilpivirine—Inflammation—Doxorubicin—sarcoma	0.000542	0.00588	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Etoposide—sarcoma	0.000537	0.00582	CcSEcCtD
Rilpivirine—Anxiety—Thiotepa—sarcoma	0.000524	0.00568	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000522	0.00566	CcSEcCtD
Rilpivirine—Abnormal dreams—Doxorubicin—sarcoma	0.00052	0.00564	CcSEcCtD
Rilpivirine—Urinary tract disorder—Etoposide—sarcoma	0.000503	0.00545	CcSEcCtD
Rilpivirine—Infection—Thiotepa—sarcoma	0.000501	0.00543	CcSEcCtD
Rilpivirine—Urethral disorder—Etoposide—sarcoma	0.000499	0.00541	CcSEcCtD
Rilpivirine—Infection—Dactinomycin—sarcoma	0.000497	0.00539	CcSEcCtD
Rilpivirine—Nervous system disorder—Thiotepa—sarcoma	0.000494	0.00536	CcSEcCtD
Rilpivirine—Skin disorder—Thiotepa—sarcoma	0.000489	0.00531	CcSEcCtD
Rilpivirine—Immune system disorder—Etoposide—sarcoma	0.00046	0.00499	CcSEcCtD
Rilpivirine—Anxiety—Mitoxantrone—sarcoma	0.000452	0.0049	CcSEcCtD
Rilpivirine—Somnolence—Thiotepa—sarcoma	0.000448	0.00486	CcSEcCtD
Rilpivirine—Infection—Vincristine—sarcoma	0.000444	0.00481	CcSEcCtD
Rilpivirine—Nervous system disorder—Vincristine—sarcoma	0.000438	0.00475	CcSEcCtD
Rilpivirine—Decreased appetite—Thiotepa—sarcoma	0.000438	0.00475	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000435	0.00472	CcSEcCtD
Rilpivirine—Decreased appetite—Dactinomycin—sarcoma	0.000435	0.00471	CcSEcCtD
Rilpivirine—Fatigue—Thiotepa—sarcoma	0.000434	0.00471	CcSEcCtD
Rilpivirine—Renal impairment—Epirubicin—sarcoma	0.000434	0.0047	CcSEcCtD
Rilpivirine—Infection—Mitoxantrone—sarcoma	0.000432	0.00469	CcSEcCtD
Rilpivirine—Fatigue—Dactinomycin—sarcoma	0.000431	0.00467	CcSEcCtD
Rilpivirine—Skin disorder—Mitoxantrone—sarcoma	0.000423	0.00458	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Thiotepa—sarcoma	0.000412	0.00447	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000409	0.00443	CcSEcCtD
Rilpivirine—Insomnia—Vincristine—sarcoma	0.000404	0.00438	CcSEcCtD
Rilpivirine—Renal impairment—Doxorubicin—sarcoma	0.000401	0.00435	CcSEcCtD
Rilpivirine—Abdominal pain—Thiotepa—sarcoma	0.000398	0.00432	CcSEcCtD
Rilpivirine—Abdominal pain—Dactinomycin—sarcoma	0.000395	0.00429	CcSEcCtD
Rilpivirine—Decreased appetite—Vincristine—sarcoma	0.000388	0.00421	CcSEcCtD
Rilpivirine—Somnolence—Mitoxantrone—sarcoma	0.000387	0.00419	CcSEcCtD
Rilpivirine—Blood creatinine increased—Epirubicin—sarcoma	0.000387	0.00419	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Vincristine—sarcoma	0.000386	0.00418	CcSEcCtD
Rilpivirine—Fatigue—Vincristine—sarcoma	0.000385	0.00418	CcSEcCtD
Rilpivirine—Decreased appetite—Mitoxantrone—sarcoma	0.000378	0.0041	CcSEcCtD
Rilpivirine—Fatigue—Mitoxantrone—sarcoma	0.000375	0.00407	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000375	0.00406	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000372	0.00403	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Vincristine—sarcoma	0.000365	0.00396	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000364	0.00395	CcSEcCtD
Rilpivirine—Asthenia—Thiotepa—sarcoma	0.000362	0.00392	CcSEcCtD
Rilpivirine—Infection—Etoposide—sarcoma	0.00036	0.0039	CcSEcCtD
Rilpivirine—Asthenia—Dactinomycin—sarcoma	0.000359	0.00389	CcSEcCtD
Rilpivirine—Blood creatinine increased—Doxorubicin—sarcoma	0.000358	0.00388	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000356	0.00386	CcSEcCtD
Rilpivirine—Abdominal pain—Vincristine—sarcoma	0.000353	0.00383	CcSEcCtD
Rilpivirine—Skin disorder—Etoposide—sarcoma	0.000352	0.00381	CcSEcCtD
Rilpivirine—Diarrhoea—Thiotepa—sarcoma	0.000345	0.00374	CcSEcCtD
Rilpivirine—Abdominal pain—Mitoxantrone—sarcoma	0.000344	0.00373	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000344	0.00373	CcSEcCtD
Rilpivirine—Diarrhoea—Dactinomycin—sarcoma	0.000342	0.00371	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000337	0.00365	CcSEcCtD
Rilpivirine—Dizziness—Thiotepa—sarcoma	0.000333	0.00361	CcSEcCtD
Rilpivirine—Somnolence—Etoposide—sarcoma	0.000322	0.00349	CcSEcCtD
Rilpivirine—Asthenia—Vincristine—sarcoma	0.000321	0.00348	CcSEcCtD
Rilpivirine—Vomiting—Thiotepa—sarcoma	0.00032	0.00347	CcSEcCtD
Rilpivirine—Vomiting—Dactinomycin—sarcoma	0.000318	0.00345	CcSEcCtD
Rilpivirine—Rash—Thiotepa—sarcoma	0.000318	0.00344	CcSEcCtD
Rilpivirine—Dermatitis—Thiotepa—sarcoma	0.000317	0.00344	CcSEcCtD
Rilpivirine—Headache—Thiotepa—sarcoma	0.000316	0.00342	CcSEcCtD
Rilpivirine—Rash—Dactinomycin—sarcoma	0.000315	0.00342	CcSEcCtD
Rilpivirine—Decreased appetite—Etoposide—sarcoma	0.000315	0.00341	CcSEcCtD
Rilpivirine—Renal failure—Epirubicin—sarcoma	0.000313	0.00339	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Etoposide—sarcoma	0.000312	0.00339	CcSEcCtD
Rilpivirine—Asthenia—Mitoxantrone—sarcoma	0.000312	0.00338	CcSEcCtD
Rilpivirine—Fatigue—Etoposide—sarcoma	0.000312	0.00338	CcSEcCtD
Rilpivirine—Diarrhoea—Vincristine—sarcoma	0.000306	0.00331	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Epirubicin—sarcoma	0.000301	0.00326	CcSEcCtD
Rilpivirine—Nausea—Thiotepa—sarcoma	0.000299	0.00324	CcSEcCtD
Rilpivirine—Diarrhoea—Mitoxantrone—sarcoma	0.000298	0.00323	CcSEcCtD
Rilpivirine—Nausea—Dactinomycin—sarcoma	0.000297	0.00322	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Etoposide—sarcoma	0.000296	0.00321	CcSEcCtD
Rilpivirine—Dizziness—Vincristine—sarcoma	0.000295	0.0032	CcSEcCtD
Rilpivirine—Renal failure—Doxorubicin—sarcoma	0.000289	0.00314	CcSEcCtD
Rilpivirine—Abdominal pain—Etoposide—sarcoma	0.000286	0.0031	CcSEcCtD
Rilpivirine—Vomiting—Vincristine—sarcoma	0.000284	0.00308	CcSEcCtD
Rilpivirine—Urinary tract disorder—Epirubicin—sarcoma	0.000282	0.00306	CcSEcCtD
Rilpivirine—Rash—Vincristine—sarcoma	0.000282	0.00305	CcSEcCtD
Rilpivirine—Dermatitis—Vincristine—sarcoma	0.000281	0.00305	CcSEcCtD
Rilpivirine—Urethral disorder—Epirubicin—sarcoma	0.00028	0.00303	CcSEcCtD
Rilpivirine—Headache—Vincristine—sarcoma	0.00028	0.00303	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000278	0.00302	CcSEcCtD
Rilpivirine—Vomiting—Mitoxantrone—sarcoma	0.000277	0.003	CcSEcCtD
Rilpivirine—Rash—Mitoxantrone—sarcoma	0.000274	0.00297	CcSEcCtD
Rilpivirine—Dermatitis—Mitoxantrone—sarcoma	0.000274	0.00297	CcSEcCtD
Rilpivirine—Headache—Mitoxantrone—sarcoma	0.000273	0.00296	CcSEcCtD
Rilpivirine—Nausea—Vincristine—sarcoma	0.000265	0.00288	CcSEcCtD
Rilpivirine—Urinary tract disorder—Doxorubicin—sarcoma	0.000261	0.00283	CcSEcCtD
Rilpivirine—Asthenia—Etoposide—sarcoma	0.00026	0.00282	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—sarcoma	0.000259	0.00281	CcSEcCtD
Rilpivirine—Nausea—Mitoxantrone—sarcoma	0.000258	0.0028	CcSEcCtD
Rilpivirine—Immune system disorder—Epirubicin—sarcoma	0.000258	0.0028	CcSEcCtD
Rilpivirine—Mental disorder—Epirubicin—sarcoma	0.00025	0.00271	CcSEcCtD
Rilpivirine—Malnutrition—Epirubicin—sarcoma	0.000249	0.00269	CcSEcCtD
Rilpivirine—Diarrhoea—Etoposide—sarcoma	0.000248	0.00268	CcSEcCtD
Rilpivirine—Dizziness—Etoposide—sarcoma	0.000239	0.00259	CcSEcCtD
Rilpivirine—Immune system disorder—Doxorubicin—sarcoma	0.000239	0.00259	CcSEcCtD
Rilpivirine—Mental disorder—Doxorubicin—sarcoma	0.000231	0.00251	CcSEcCtD
Rilpivirine—Vomiting—Etoposide—sarcoma	0.00023	0.00249	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—sarcoma	0.00023	0.00249	CcSEcCtD
Rilpivirine—Rash—Etoposide—sarcoma	0.000228	0.00247	CcSEcCtD
Rilpivirine—Dermatitis—Etoposide—sarcoma	0.000228	0.00247	CcSEcCtD
Rilpivirine—Headache—Etoposide—sarcoma	0.000227	0.00246	CcSEcCtD
Rilpivirine—Nausea—Etoposide—sarcoma	0.000215	0.00233	CcSEcCtD
Rilpivirine—Anxiety—Epirubicin—sarcoma	0.000211	0.00229	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00021	0.00228	CcSEcCtD
Rilpivirine—Dry mouth—Epirubicin—sarcoma	0.000207	0.00224	CcSEcCtD
Rilpivirine—Infection—Epirubicin—sarcoma	0.000202	0.00219	CcSEcCtD
Rilpivirine—Nervous system disorder—Epirubicin—sarcoma	0.000199	0.00216	CcSEcCtD
Rilpivirine—Skin disorder—Epirubicin—sarcoma	0.000197	0.00214	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—sarcoma	0.000195	0.00212	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000194	0.00211	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—sarcoma	0.000192	0.00208	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—sarcoma	0.000187	0.00202	CcSEcCtD
Rilpivirine—Nervous system disorder—Doxorubicin—sarcoma	0.000184	0.002	CcSEcCtD
Rilpivirine—Insomnia—Epirubicin—sarcoma	0.000184	0.00199	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—sarcoma	0.000182	0.00198	CcSEcCtD
Rilpivirine—Somnolence—Epirubicin—sarcoma	0.00018	0.00196	CcSEcCtD
Rilpivirine—Decreased appetite—Epirubicin—sarcoma	0.000176	0.00191	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000175	0.0019	CcSEcCtD
Rilpivirine—Fatigue—Epirubicin—sarcoma	0.000175	0.0019	CcSEcCtD
Rilpivirine—Insomnia—Doxorubicin—sarcoma	0.00017	0.00184	CcSEcCtD
Rilpivirine—Somnolence—Doxorubicin—sarcoma	0.000167	0.00181	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Epirubicin—sarcoma	0.000166	0.0018	CcSEcCtD
Rilpivirine—Decreased appetite—Doxorubicin—sarcoma	0.000163	0.00177	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000162	0.00176	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—sarcoma	0.000162	0.00175	CcSEcCtD
Rilpivirine—Abdominal pain—Epirubicin—sarcoma	0.00016	0.00174	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000154	0.00166	CcSEcCtD
Rilpivirine—Abdominal pain—Doxorubicin—sarcoma	0.000148	0.00161	CcSEcCtD
Rilpivirine—Asthenia—Epirubicin—sarcoma	0.000146	0.00158	CcSEcCtD
Rilpivirine—Diarrhoea—Epirubicin—sarcoma	0.000139	0.0015	CcSEcCtD
Rilpivirine—Asthenia—Doxorubicin—sarcoma	0.000135	0.00146	CcSEcCtD
Rilpivirine—Dizziness—Epirubicin—sarcoma	0.000134	0.00145	CcSEcCtD
Rilpivirine—Vomiting—Epirubicin—sarcoma	0.000129	0.0014	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—sarcoma	0.000128	0.00139	CcSEcCtD
Rilpivirine—Rash—Epirubicin—sarcoma	0.000128	0.00139	CcSEcCtD
Rilpivirine—Dermatitis—Epirubicin—sarcoma	0.000128	0.00139	CcSEcCtD
Rilpivirine—Headache—Epirubicin—sarcoma	0.000127	0.00138	CcSEcCtD
Rilpivirine—Dizziness—Doxorubicin—sarcoma	0.000124	0.00135	CcSEcCtD
Rilpivirine—Nausea—Epirubicin—sarcoma	0.000121	0.00131	CcSEcCtD
Rilpivirine—Vomiting—Doxorubicin—sarcoma	0.000119	0.00129	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—sarcoma	0.000118	0.00128	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—sarcoma	0.000118	0.00128	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—sarcoma	0.000118	0.00127	CcSEcCtD
Rilpivirine—Nausea—Doxorubicin—sarcoma	0.000112	0.00121	CcSEcCtD
